CONMED CORPORATION Cash and Restricted Cash
CONMED CORPORATION (CNMD) had Cash and Restricted Cash of $37.33 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $37.33M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40.82M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $38.93M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.94M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $37.33M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $40.82M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $38.93M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $33.94M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $35.48M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $24.46M 10-Q · filed 2026-07-29 |
| 2024-09-30 | $38.47M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $28.87M 10-Q · filed 2025-07-31 |
| 2024-03-31 | $33.85M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $24.30M 10-K · filed 2026-02-17 |
| 2023-09-30 | $30.50M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $27.85M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $26.49M 10-Q · filed 2024-04-25 |
| 2022-12-31 | $28.94M 10-K · filed 2026-02-17 |
| 2022-09-30 | $33.35M 10-Q · filed 2023-10-26 |
| 2022-06-30 | $53.15M 10-Q · filed 2023-07-27 |
| 2022-03-31 | $24.86M 10-Q · filed 2023-04-27 |
| 2021-12-31 | $20.85M 10-K · filed 2025-02-18 |
| 2021-09-30 | $31.51M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $46.39M 10-Q · filed 2022-07-28 |
| 2021-03-31 | $36.77M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $27.36M 10-K · filed 2024-02-28 |
| 2020-09-30 | $35.60M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $34.98M 10-Q · filed 2021-07-29 |
| 2020-03-31 | $24.31M 10-Q · filed 2021-04-29 |
| 2019-12-31 | $25.86M 10-K · filed 2023-02-21 |
| 2019-09-30 | $30.07M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $22.55M 10-Q · filed 2020-07-30 |
| 2019-03-31 | $23.41M 10-Q · filed 2020-04-30 |
| 2018-12-31 | $17.51M 10-K · filed 2022-02-22 |
| 2017-12-31 | $32.62M 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |